Annual ROE
-168.50%
-80.13%-90.68%
December 31, 2023
Summary
- As of February 20, 2025, LXRX annual return on equity is -168.50%, with the most recent change of -80.13% (-90.68%) on December 31, 2023.
- During the last 3 years, LXRX annual ROE has fallen by -125.66% (-293.32%).
- LXRX annual ROE is now -158.72% below its all-time high of 286.97%, reached on December 31, 2019.
Performance
LXRX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-115.11%
-8.49%-7.96%
September 30, 2024
Summary
- As of February 20, 2025, LXRX quarterly return on equity is -115.11%, with the most recent change of -8.49% (-7.96%) on September 30, 2024.
- Over the past year, LXRX quarterly ROE has increased by +6.50% (+5.34%).
- LXRX quarterly ROE is now -104.85% below its all-time high of 2372.37%, reached on September 30, 2019.
Performance
LXRX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
LXRX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -90.7% | +5.3% |
| 3 y3 years | -293.3% | -32.3% |
| 5 y5 years | +70.7% | -104.8% |
LXRX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -159.2% | at low | -82.7% | +18.9% |
| 5 y | 5-year | -158.7% | at low | -125.6% | +18.9% |
| alltime | all time | -158.7% | +70.7% | -104.8% | +93.6% |
Lexicon Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -115.11%(+8.0%) |
| Jun 2024 | - | -106.62%(-12.3%) |
| Mar 2024 | - | -121.61%(-14.3%) |
| Dec 2023 | -168.50%(+90.7%) | -141.89%(+21.4%) |
| Sep 2023 | - | -116.92%(+8.5%) |
| Jun 2023 | - | -107.79%(+0.1%) |
| Mar 2023 | - | -107.66%(+13.7%) |
| Dec 2022 | -88.37%(+35.9%) | -94.70%(+8.8%) |
| Sep 2022 | - | -87.01%(-0.9%) |
| Jun 2022 | - | -87.84%(+23.1%) |
| Mar 2022 | - | -71.34%(+13.2%) |
| Dec 2021 | -65.01%(+51.8%) | -63.01%(+24.9%) |
| Sep 2021 | - | -50.45%(-238.6%) |
| Jun 2021 | - | 36.40%(-348.3%) |
| Mar 2021 | - | -14.66%(-79.7%) |
| Dec 2020 | -42.84%(-114.9%) | -72.28%(-42.6%) |
| Sep 2020 | - | -126.01%(-267.5%) |
| Jun 2020 | - | 75.22%(-60.1%) |
| Mar 2020 | - | 188.74%(-58.0%) |
| Dec 2019 | 286.97%(-149.8%) | 449.25%(-81.1%) |
| Sep 2019 | - | 2372.37%(+1008.8%) |
| Jun 2019 | - | 213.95%(-43.3%) |
| Mar 2019 | - | 377.33%(-121.0%) |
| Dec 2018 | -575.96%(+428.4%) | -1794.83%(+293.9%) |
| Sep 2018 | - | -455.63%(+93.0%) |
| Jun 2018 | - | -236.09%(+50.4%) |
| Mar 2018 | - | -157.01%(+39.1%) |
| Dec 2017 | -109.00%(+83.8%) | -112.85%(+21.3%) |
| Sep 2017 | - | -93.00%(+16.0%) |
| Jun 2017 | - | -80.17%(+15.6%) |
| Mar 2017 | - | -69.38%(+16.0%) |
| Dec 2016 | -59.31%(+3516.5%) | -59.82%(+512.3%) |
| Sep 2016 | - | -9.77%(+7.6%) |
| Jun 2016 | - | -9.08%(+93.6%) |
| Mar 2016 | - | -4.69%(+152.2%) |
| Dec 2015 | -1.64%(-96.3%) | -1.86%(-95.9%) |
| Sep 2015 | - | -44.98%(-12.6%) |
| Jun 2015 | - | -51.46%(-7.5%) |
| Mar 2015 | - | -55.61%(-12.5%) |
| Dec 2014 | -44.16%(-7.4%) | -63.52%(-23.5%) |
| Sep 2014 | - | -83.03%(+29.9%) |
| Jun 2014 | - | -63.94%(+11.9%) |
| Mar 2014 | - | -57.12%(+18.5%) |
| Dec 2013 | -47.67%(+22.0%) | -48.21%(+0.4%) |
| Sep 2013 | - | -48.00%(+7.1%) |
| Jun 2013 | - | -44.80%(+7.5%) |
| Mar 2013 | - | -41.68%(+0.7%) |
| Dec 2012 | -39.06% | -41.41%(-14.3%) |
| Sep 2012 | - | -48.30%(-1.9%) |
| Jun 2012 | - | -49.25%(-2.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | -50.65%(-1.7%) |
| Dec 2011 | -42.68%(-13.9%) | -51.53%(+7.5%) |
| Sep 2011 | - | -47.94%(+10.0%) |
| Jun 2011 | - | -43.60%(+11.7%) |
| Mar 2011 | - | -39.04%(-0.8%) |
| Dec 2010 | -49.58%(+7.6%) | -39.35%(-8.1%) |
| Sep 2010 | - | -42.84%(-1.9%) |
| Jun 2010 | - | -43.65%(-6.3%) |
| Mar 2010 | - | -46.59%(-8.4%) |
| Dec 2009 | -46.08%(+44.6%) | -50.87%(+15.4%) |
| Sep 2009 | - | -44.09%(+6.4%) |
| Jun 2009 | - | -41.42%(+11.6%) |
| Mar 2009 | - | -37.12%(+15.6%) |
| Dec 2008 | -31.87%(+0.9%) | -32.10%(+12.7%) |
| Sep 2008 | - | -28.48%(+5.3%) |
| Jun 2008 | - | -27.04%(-4.6%) |
| Mar 2008 | - | -28.35%(-18.8%) |
| Dec 2007 | -31.60%(-50.2%) | -34.90%(-29.5%) |
| Sep 2007 | - | -49.51%(-36.2%) |
| Jun 2007 | - | -77.57%(-13.5%) |
| Mar 2007 | - | -89.66%(+20.4%) |
| Dec 2006 | -63.41%(+81.1%) | -74.45%(+54.7%) |
| Sep 2006 | - | -48.14%(+6.7%) |
| Jun 2006 | - | -45.11%(+18.5%) |
| Mar 2006 | - | -38.08%(+2.7%) |
| Dec 2005 | -35.02%(+6.8%) | -37.09%(-8.8%) |
| Sep 2005 | - | -40.68%(+10.1%) |
| Jun 2005 | - | -36.95%(+5.3%) |
| Mar 2005 | - | -35.08%(+3.9%) |
| Dec 2004 | -32.78%(-14.2%) | -33.75%(-17.1%) |
| Sep 2004 | - | -40.69%(+2.1%) |
| Jun 2004 | - | -39.84%(+1.1%) |
| Mar 2004 | - | -39.41%(-0.5%) |
| Dec 2003 | -38.20%(+24.3%) | -39.62%(+3.5%) |
| Sep 2003 | - | -38.29%(-1.5%) |
| Jun 2003 | - | -38.87%(+12.5%) |
| Mar 2003 | - | -34.55%(+12.5%) |
| Dec 2002 | -30.74%(+86.2%) | -30.72%(+11.2%) |
| Sep 2002 | - | -27.63%(+24.7%) |
| Jun 2002 | - | -22.16%(+12.9%) |
| Mar 2002 | - | -19.63%(+17.3%) |
| Dec 2001 | -16.51%(-31.5%) | -16.73%(+10.4%) |
| Sep 2001 | - | -15.16%(+15.4%) |
| Jun 2001 | - | -13.14%(+7.2%) |
| Mar 2001 | - | -12.26%(-24.9%) |
| Dec 2000 | -24.10%(-84.4%) | -16.33%(+26.4%) |
| Sep 2000 | - | -12.92%(-17.3%) |
| Jun 2000 | - | -15.62%(-92.1%) |
| Mar 2000 | - | -196.55% |
| Dec 1999 | -154.05% | - |
FAQ
- What is Lexicon Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals annual ROE year-on-year change?
- What is Lexicon Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Lexicon Pharmaceuticals?
- What is Lexicon Pharmaceuticals quarterly ROE year-on-year change?
What is Lexicon Pharmaceuticals annual return on equity?
The current annual ROE of LXRX is -168.50%
What is the all time high annual ROE for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high annual return on equity is 286.97%
What is Lexicon Pharmaceuticals annual ROE year-on-year change?
Over the past year, LXRX annual return on equity has changed by -80.13% (-90.68%)
What is Lexicon Pharmaceuticals quarterly return on equity?
The current quarterly ROE of LXRX is -115.11%
What is the all time high quarterly ROE for Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals all-time high quarterly return on equity is 2372.37%
What is Lexicon Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, LXRX quarterly return on equity has changed by +6.50% (+5.34%)